Acer therapeutics highlights key 2022 achievements and pipeline advancements, and provides anticipated 2023 milestones

Newton, mass., jan. 09, 2023 (globe newswire) -- newton, ma – january 09, 2023 – acer therapeutics inc. (nasdaq: acer), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious, rare and life-threatening diseases with significant unmet medical needs, today announced a corporate update and provided anticipated key development milestones for 2023.
ACER Ratings Summary
ACER Quant Ranking